INHIBRX BIOSCIENCES INC (INBX) Stock Earnings & Estimates
USA - NASDAQ:INBX - US45720N1037 - Common Stock
28.33 USD
+1.21 (+4.46%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.19M -69.71% | 1.8M -17.81% | 200K -88.89% | 1.326M 563.00% | 4.386M 230.77% | 344.61M 7,757.05% | 353.69M 2.63% | 510.16M 44.24% | 710M 39.17% | 753.51M 6.13% | |
| EBITDA YoY % growth | -127.89M -69.71% | -218.03M -70.48% | -329.163M -50.97% | -91.676M 72.15% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -129.12M -68.65% | -219.221M -69.78% | -331.448M -51.19% | -131.103M 60.45% | -132.453M -1.03% | -21.33M 83.90% | -74.448M -249.02% | 71.623M 196.21% | 154.97M 116.37% | 170.27M 9.87% | |
| Operating Margin | -5,895.89% | -12,178.94% | -165,724.00% | -9,887.08% | -3,019.91% | -6.19% | -21.05% | 14.04% | 21.83% | 22.60% | |
| EPS YoY % growth | -3.62 -68.37% | -5.03 -38.95% | 118.11 2,448.11% | -10.95 -109.27% | -10.18 7.10% | -0.50 95.09% | -1.25 -151.02% | 0.91 172.36% | 1.96 115.73% | 2.15 9.90% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.75 38.30% | -1.79 42.20% | -1.95 30.20% | -2.56 -38.11% | -2.40 -36.85% | -2.41 -35.07% |
| Revenue Q2Q % growth | -100.00% | -100.00% | 1.958M | 2.448M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.556M 36.84% | -29.851M 40.21% | -32.062M 30.56% | -34.295M -25.22% | -48.766M -65.00% | -48.878M -63.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.85 -101.47% | -2.82 | 0.97 | 34.31% |
| Q1 2025 Q2Q % growth | -2.80 -94.44% | -2.90 | 0.10 | 3.29% |
| Q4 2024 Q2Q % growth | -3.09 -78.61% | -2.94 | -0.15 | -4.97% |
| Q3 2024 Q2Q % growth | -2.84 -158.18% | -3.45 | 0.61 | 17.60% |
| Q2 2024 Q2Q % growth | 125.48 11,718.52% | -3.67 | 129.15 | 3,517.21% |
| Q1 2024 Q2Q % growth | -1.44 -28.57% | -1.06 | -0.38 | -35.75% |
| Q4 2023 Q2Q % growth | -1.73 -82.11% | -1.06 | -0.67 | -63.61% |
| Q3 2023 Q2Q % growth | -1.10 -22.22% | -1.03 | -0.07 | -6.78% |
| Q2 2023 Q2Q % growth | -1.08 -11.34% | -1.05 | -0.03 | -2.50% |
| Q1 2023 Q2Q % growth | -1.12 -40.00% | -0.86 | -0.26 | -30.10% |
| Q4 2022 Q2Q % growth | -0.95 -72.73% | -0.80 | -0.15 | -18.19% |
| Q3 2022 Q2Q % growth | -0.90 -66.67% | -0.96 | 0.06 | 6.23% |
| Q2 2022 Q2Q % growth | -0.97 -76.36% | -0.79 | -0.18 | -22.16% |
| Q1 2022 Q2Q % growth | -0.80 -56.86% | -0.61 | -0.19 | -30.87% |
| Q4 2021 Q2Q % growth | -0.55 -17.02% | -0.58 | 0.03 | 5.79% |
| Q3 2021 Q2Q % growth | -0.54 29.87% | -0.58 | 0.04 | 6.85% |
| Q2 2021 Q2Q % growth | -0.55 | -0.57 | 0.02 | 2.93% |
| Q1 2021 Q2Q % growth | -0.51 | -0.60 | 0.09 | 15.04% |
| Q4 2020 Q2Q % growth | -0.47 | -0.55 | 0.08 | 14.98% |
| Q3 2020 Q2Q % growth | -0.77 | -0.62 | -0.15 | -25.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.3M 1,200.00% | 1.3M | % | |
| Q4 2024 Q2Q % growth | 100K -93.88% | 100K | % | |
| Q2 2024 Q2Q % growth | 100K 233.33% | 100K | % | |
| Q1 2024 Q2Q % growth | -100.00% | 51K | -51K | -100.00% |
| Q4 2023 Q2Q % growth | 1.634M 505.19% | 51K | 1.583M | 3,103.92% |
| Q3 2023 Q2Q % growth | 120K -100.00% | % | ||
| Q2 2023 Q2Q % growth | 30K -95.77% | 30K | % | |
| Q1 2023 Q2Q % growth | 17K -98.17% | 153K | -136K | -88.89% |
| Q4 2022 Q2Q % growth | 270K -90.56% | 809.88K | -539.88K | -66.66% |
| Q3 2022 Q2Q % growth | 280K -88.93% | 645.997K | -365.997K | -56.66% |
| Q2 2022 Q2Q % growth | 710K -25.26% | 1.09M | -380K | -34.86% |
| Q1 2022 Q2Q % growth | 930K 4.49% | 1.124M | -194K | -17.26% |
| Q4 2021 Q2Q % growth | 2.86M 2.88% | 1.742M | 1.118M | 64.18% |
| Q3 2021 Q2Q % growth | 2.53M -57.12% | 1.02M | 1.51M | 148.04% |
| Q2 2021 Q2Q % growth | 950K -71.56% | 841.5K | 108.5K | 12.89% |
| Q1 2021 Q2Q % growth | 890K 2.30% | 943.5K | -53.5K | -5.67% |
| Q4 2020 Q2Q % growth | 2.78M -78.96% | 1.014M | 1.766M | 174.16% |
| Q3 2020 Q2Q % growth | 5.9M | 1.02M | 4.88M | 478.43% |
| Q2 2020 Q2Q % growth | 3.34M 4.05% | % | ||
| Q1 2020 Q2Q % growth | 870K -89.79% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 35.07% | 38.49% | 0% | 4.15% |
| Revenue | N/A | N/A | N/A | N/A |